← Return to Statistics on progression free survival while on SSA / Lanreotide
DiscussionStatistics on progression free survival while on SSA / Lanreotide
Neuroendocrine Tumors (NETs) | Last Active: Feb 19 10:58pm | Replies (21)Comment receiving replies
Replies to "Pete, I don't know most of the acronyms you are using. Good luck."
Hi Tomrennie, please see answer from Coleen Young below. Good luck in your journey!
Allow me to be the acronym buster for this discussion:
- SSA = Somatostatin analogue
https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment/somatostatin-analogues/what-are
The most common somatostatin analogue drugs used are octreotide and lanreotide
- NELM = neuroendocrine liver metastases
- PFS = progression free survival
Thanks for asking on behalf of everyone, Tom.